Eli Lilly reported higher third-quarter profit and raised its outlook on the back of surging demand for its weight-loss drugs Mounjaro and Zepbound
Eli Lilly reported higher profit and raised its outlook on surging demand for its weight-loss drugs, sending its shares higher.
Source link
About The Author
